candesartan has been researched along with Hypertension, Pulmonary in 3 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Administration of enalaprilat and candesartan did not affect the Ppa-Ppao gradient at baseline or during hypoxia." | 3.72 | Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs. ( Bergmann, P; Biarent, D; Hubloue, I; Kerbaul, F; Leeman, M; Milani, GM; Naeije, R; Rondelet, B; Staroukine, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hünseler, C | 1 |
| Paneitz, A | 1 |
| Friedrich, D | 1 |
| Lindner, U | 1 |
| Oberthuer, A | 1 |
| Körber, F | 1 |
| Schmitt, K | 1 |
| Welzing, L | 1 |
| Müller, A | 1 |
| Herkenrath, P | 1 |
| Hoppe, B | 1 |
| Gortner, L | 1 |
| Roth, B | 1 |
| Kattner, E | 1 |
| Schaible, T | 1 |
| Hubloue, I | 1 |
| Rondelet, B | 1 |
| Kerbaul, F | 1 |
| Biarent, D | 1 |
| Milani, GM | 1 |
| Staroukine, M | 1 |
| Bergmann, P | 1 |
| Naeije, R | 1 |
| Leeman, M | 1 |
| Kishi, K | 1 |
| Jin, D | 1 |
| Takai, S | 1 |
| Muramatsu, M | 1 |
| Katayama, H | 1 |
| Tamai, H | 1 |
| Miyazaki, M | 1 |
3 other studies available for candesartan and Hypertension, Pulmonary
| Article | Year |
|---|---|
Angiotensin II receptor blocker induced fetopathy: 7 cases.
Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents | 2011 |
Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; A | 2004 |
Role of chymase-dependent angiotensin II formation in monocrotaline-induced pulmonary hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; | 2006 |